Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160314 · ClinicalTrials.gov registry record · NA
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 224
- Enrollment target
NCT02160314: Completed NA study, sponsored by Procter and Gamble.
NCT02160314 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 224 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160314, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
Study Summary
This study will evaluate the safety of the pessary device by objective evaluation of vaginal wall integrity and subjective assessment of comfort during in-use conditions.
Primary Outcome
proportion of intent-to-treat subjects who experience a treatment-emergent serious adverse event
Interventions
- DEVICE pessary
- DEVICE Absorbent pad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02160314 record still lists
NCT02160314 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which pessary is the first listed.
NCT02160314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02160314 about?
NCT02160314 is a clinical study titled "A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence". This study will evaluate the safety of the pessary device by objective evaluation of vaginal wall integrity and subjective assessment of comfort during in-use conditions.
What is the current status of trial NCT02160314?
This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2014-05. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02160314?
The interventions under investigation include: pessary (DEVICE), Absorbent pad (DEVICE).
Who is sponsoring clinical trial NCT02160314?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02160314's enrollment target sits among peer trials
224 478th of 2000 higher than 1,520 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia